| Literature DB >> 32652061 |
Kosuke Fujimoto1, Yasumasa Kimura2, Masaki Shimohigoshi3, Takeshi Satoh2, Shintaro Sato4, Georg Tremmel5, Miho Uematsu3, Yunosuke Kawaguchi3, Yuki Usui2, Yoshiko Nakano3, Tetsuya Hayashi3, Koji Kashima6, Yoshikazu Yuki6, Kiyoshi Yamaguchi7, Yoichi Furukawa7, Masanori Kakuta5, Yutaka Akiyama8, Rui Yamaguchi5, Sheila E Crowe9, Peter B Ernst10, Satoru Miyano5, Hiroshi Kiyono11, Seiya Imoto12, Satoshi Uematsu13.
Abstract
The application of bacteriophages (phages) is proposed as a highly specific therapy for intestinal pathobiont elimination. However, the infectious associations between phages and bacteria in the human intestine, which is essential information for the development of phage therapies, have yet to be fully elucidated. Here, we report the intestinal viral microbiomes (viromes), together with bacterial microbiomes (bacteriomes), in 101 healthy Japanese individuals. Based on the genomic sequences of bacteriomes and viromes from the same fecal samples, the host bacteria-phage associations are illustrated for both temperate and virulent phages. To verify the usefulness of the comprehensive host bacteria-phage information, we screened Clostridioides difficile-specific phages and identified antibacterial enzymes whose activity is confirmed both in vitro and in vivo. These comprehensive metagenome analyses reveal not only host bacteria-phage associations in the human intestine but also provide vital information for the development of phage therapies against intestinal pathobionts.Entities:
Keywords: CRISPR; Clostridioides difficile infection; bacteriome; bacteriophage; host bacteria-phage association; metagenome analysis; prophage; virome
Mesh:
Substances:
Year: 2020 PMID: 32652061 DOI: 10.1016/j.chom.2020.06.005
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023